Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OncoArendi Therapeutics

OncoArendi Therapeutics
2012 FOUNDED
PUBLIC STATUS
81-90 EMPLOYEES
OAT STOCK SYMBOL
$3.30 SHARE PRICE (As of Wednesday Closing)
Description

Oncoarendi Therapeutics SA is a biopharmaceutical company engaged in discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Żwirki i Wigury 101
  • Warszawa, 02-089
  • Poland

+48 22 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OncoArendi Therapeutics’s full profile, request a free trial.

OncoArendi Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.42 - $5.49 $45.1M $3.15 -$0.09 8.83K 13.7M

OncoArendi Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 29,859 36,360
Revenue 1 1 2 2
EBITDA (1,373) (1,406) (671) (604)
Net Income (1,228) (1,231) (636) (614)
Total Assets 21,248 22,857 9,930 3,705
Total Debt 627 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoArendi Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore OncoArendi Therapeutics‘s full profile, request access.

Request full access to PitchBook

OncoArendi Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Marcin Szumowski Chief Executive Officer & President
Sławomir Broniarek Chief Financial Officer & Board Member
Stanisław Pikul Ph.D Co-Founder, Vice President, Development & Board Member

OncoArendi Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
Sławomir Broniarek OncoArendi Therapeutics Chief Financial Officer & Board Member 000 0000
Stanisław Pikul Ph.D OncoArendi Therapeutics Co-Founder, Vice President, Development & Board Member 000 0000